DailyDoctor Archive Specialties Get app
Back to the 13 October 2026 edition

Research · 04 of 06

Hyperuricaemia and obesity: three diets, same urate fall, flare risk in week one

Choose the weight-loss diet a patient can sustain, and plan for a first-week gout flare.

Design
Randomised, open-label, active-comparator, 12 weeks
Population
102 men with overweight or obesity and hyperuricaemia
Primary outcome
Change in serum urate at week 12
Effect
−0.89 (CRD), −0.79 (DASH), −0.50 mg/dL (low-purine); P=0.48 between groups

In a 12-week open-label trial, 102 men with overweight or obesity and hyperuricaemia were randomised to calorie-restricted carbohydrate-restricted, DASH or low-purine diets. Eighty-five completed follow-up.

Weight loss averaged 8.47 kg (9.3%) with no difference between diets. Serum urate fell by 0.89, 0.79 and 0.50 mg/dL respectively, without a significant difference between groups. Capillary urate monitoring showed a transient rise in the first week, coinciding with the peak in gout flares. DASH had the best adherence and less lean mass loss than the carbohydrate-restricted diet.

For the patient with obesity and raised urate, the diet that is easiest to follow is reasonable, and DASH did well on that. The week-one flare window is the clinically useful finding: it is worth warning patients and considering flare cover when a structured weight-loss diet begins.

  • Offer the calorie-restricted pattern the patient will stick to; urate fell similarly on all three.
  • DASH had the best adherence and preserved more lean mass than carbohydrate restriction.
  • Warn patients with gout that flares may increase in the first week of a weight-loss diet.
  • Consider flare prophylaxis in established gout when starting structured dieting.

Why it matters

Low-purine advice is often given as the default, but it did no better for urate and was harder to keep.

Don't overread it

A small, men-only, 12-week trial with 17% dropout cannot show that the diets are truly equivalent.

The statistics, in plain English

A between-group P of 0.48 means the differences in urate fall could easily be chance; with 85 completers the trial was too small to rule out a modest real difference.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

neuropathyobesityglp1cgmtype1type2

Tomorrow morning, before your first patient

One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app